TipRanks
Go Ultimate55% OFF

Hightide Therapeutics Inc (2511) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

2511 Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Hightide Therapeutics Inc in the past 3 months

2511 Stock 12 Month Forecast

HKD 5.60▲(80.65% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Hightide Therapeutics Inc in the last 3 months. The average price target is HKD 5.60 with a high forecast of HKD 5.60 and a low forecast of HKD 5.60. The average price target represents a 80.65% change from the last price of HKD 3.10.
Highest Price TargetHKD 5.60Average Price TargetHKD 5.60Lowest Price TargetHKD 5.60

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:2511
Price TargetFollowArticle
CGS International Analyst forecast on HK:2511Unknown AnalystNot RankedCGS InternationalHKD 5.60buy80.65%UpsideReiterated09/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hightide Therapeutics Inc

3 Months
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/1 ratings generated profit
0%
Average Return
-26.00%

Copying Anthropic Health Care HK's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -26.00% per trade.

1 Year
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/1 ratings generated profit
0%
Average Return
-9.10%

Copying Anthropic Health Care HK's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -9.10% per trade.

2 Years
Anthropic Health Care HK
Anthropic Health Care HKTipRanks - Anthropic
Success Rate0/1 ratings generated profit
0%
Average Return
-9.10%

Copying Anthropic Health Care HK's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.10% per trade.

2511 Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 2511
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00111
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00111

In the current month, 2511 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2511 average Analyst price target in the past 3 months is 5.60.

2511 Financial Forecast

HKD -2HKD -1.5HKD -1HKD -0.5HKD 0Q2 2025Q2 2026Q4 2026
ConsensusHKD -0.33

2511 Earnings Forecast

Next quarter’s earnings estimate for 2511 is -HKD 0.33 with a range of ― to ―. The previous quarter’s EPS was -HKD 0.33. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

HKD -1HKD -0.5HKD 0HKD 0.5HKD 1Q2 2025Q2 2026Q4 2026
ConsensusHKD 0.00

2511 Sales Forecast

Next quarter’s sales forecast for 2511 is HKD 0 with a range of ― to ―. The previous quarter’s sales results were HKD 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2511 Stock Forecast FAQ

What is HK:2511’s average 12-month price target, according to analysts?
Based on analyst ratings, Hightide Therapeutics Inc’s 12-month average price target is HK$5.60.
What is HK:2511’s upside potential, based on the analysts’ average price target?
Hightide Therapeutics Inc has 80.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hightide Therapeutics Inc a Buy, Sell or Hold?
Hightide Therapeutics Inc has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hightide Therapeutics Inc’s share price target?
The average share price target for Hightide Therapeutics Inc is HK$5.60. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$5.60, and the lowest forecast is HK$5.60. The average share price target represents a 80.65% increase from the current price of HK$3.1.
What do analysts say about Hightide Therapeutics Inc?
Hightide Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Hightide Therapeutics Inc?
To buy shares of HK:2511, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.